Tax withholding prompts a proposed 11,087-share sale by Cue Biopharma (CUE) officer Shao-Lee Lin.
Alpha Vantage · Stock Titan · · AI-summarised by FinFlash
Shao-Lee Lin, an officer and director of Cue Biopharma, Inc. (CUE), has proposed to sell 11,087 common shares on October 12, 2026, for an aggregate market value of $305,490.35. This sale is intended to cover tax withholding obligations related to restricted stock unit vesting and is not a discretionary transaction. Lin has previously reported selling shares on August 12 and August 13, 2026.
Understand the context
Published information may change. Summaries can contain errors; check the original source. Educational information only, not investment advice.